Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

2.96
+0.23008.42%
Post-market: 2.88-0.0800-2.70%19:59 EDT
Volume:584.93K
Turnover:1.70M
Market Cap:24.79M
PE:-0.67
High:3.12
Open:2.64
Low:2.64
Close:2.73
52wk High:22.20
52wk Low:2.02
Shares:8.38M
Float Shares:6.31M
Volume Ratio:0.08
T/O Rate:9.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4145
EPS(LYR):-9.4201
ROE:-424.97%
ROA:-84.22%
PB:6.15
PE(LYR):-0.31

Loading ...

Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns

TIPRANKS
·
May 10

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 09

Femasys Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Femasys Q1 sales rise on FemBloc demand

Reuters
·
May 09

Femasys Inc. Q1 EPS USD 0

THOMSON REUTERS
·
May 09

Femasys swings to Q1 profit of 846,100; sales rise 24.5% to 424,889

Reuters
·
May 09

Femasys Q1 Sales $424.889K Miss $767.000K Estimate

Benzinga Earnings
·
May 09

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

THOMSON REUTERS
·
May 09

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

GlobeNewswire
·
May 05

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 05

Femasys Shareholders Approve Reverse Split and Financing Plans

TIPRANKS
·
Apr 30

Femasys shareholders approved reverse stock split amendment at special meeting

Reuters
·
Apr 30

Analysts Are Bullish on These Healthcare Stocks: Femasys (FEMY), ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Apr 28

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

GlobeNewswire
·
Apr 22

Lake Street initiates Femasys coverage with Buy rating

Reuters
·
Apr 16

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

GlobeNewswire
·
Apr 16

Femasys Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 03

Analysts Are Bullish on These Healthcare Stocks: Femasys (FEMY), Context Therapeutics (CNTX)

TIPRANKS
·
Apr 02

Femasys COO John Charles Canning files initial beneficial ownership statement

Reuters
·
Apr 02

Femasys Names John Canning as New Chief Operating Officer

TIPRANKS
·
Apr 02